ClinicalTrials.Veeva

Menu

Biobased Polyester Versus Synthetic Fiberglass Casts for Treating Stable Upper Limb Fractures in Children

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

Upper Limb Fracture

Treatments

Other: the biobased polyester cast
Other: the synthetic fiberglass cast

Study type

Interventional

Funder types

Other

Identifiers

NCT06102603
110245-F

Details and patient eligibility

About

From Feb 2022 to Nov 2022, we undertook a single-center prospective randomized trial involving 100 children with cast-immobilized stable upper limb fractures. These patients were randomized into either biobased polyester or synthetic fiberglass groups. All patients were regularly followed up till the cast removal which occurred approximately 3-4 weeks after immobilizing. Objective clinical findings and subjective patient questionnaire were all collected and analyzed.

Full description

The clinical trial was approved by the research ethics review committee of the author's hospital and informed consent was obtained from the legal guardian of each patient. Between Feb 2022 and Nov 2022, all children (age range, 4-15 years) with radiography-diagnosed stable upper limb fractures (including radius, ulna, and distal humerus fractures such as Garland type I supracondylar fractures of the humerus) [9] diagnosed at the orthopedic outpatient clinic or emergency room of a tertiary trauma center hospital were eligible for recruitment.

Enrollment

100 patients

Sex

All

Ages

4 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stable upper limb fractures (including radius, ulna, and distal humerus fractures such as Garland type I supracondylar fractures of the humerus) diagnosed at the orthopedic outpatient clinic or emergency room of a tertiary trauma center hospital

Exclusion criteria

  • displaced or unstable fractures indicated for close or open reduction and fixation
  • previous surgeries to the affected upper limb
  • history of any chronic skin pathology (e.g., atopic dermatitis)
  • known allergy to cast materials

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

the biobased polyester cast group
Experimental group
Description:
biobased polyester cast was applied
Treatment:
Other: the biobased polyester cast
the synthetic fiberglass cast group
Active Comparator group
Description:
synthetic fiberglass cast was applied
Treatment:
Other: the synthetic fiberglass cast

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems